Greenberg Traurig, LLP represented Huadong Medicine Co., a Chinese publicly traded pharmaceutical company, in negotiating two strategic licensing agreements to develop and commercialize market-leading medications in
New York (PRWEB) June 21, 2023 Global law firm Greenberg Traurig, LLP has 172 attorneys and 48 practices recognized in The Legal 500 United States 2023
Boston, MA (PRWEB) September 09, 2022 David J. Dykeman, co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group, and co-managing
Wayne H. Elowe, co-chair of the Life Sciences and Medical Technology Group at global law firm Greenberg Traurig, LLP and co-chair of the firm’s Atlanta Corporate Practice, led the Greenberg Traurig team representing Huadong Medicine Co., Ltd., one of the leading pharmaceutical companies in China with a focus on oncology and Antibody-drug Conjugates research, development, and commercialization, on two large licensing deals, both of which closed in February 2022. These deals mark the continuation of a longstanding relationship between Huadong Medicine and Greenberg Traurig Shareholders Elowe and Dawn (Dan) Zhang (Shanghai) who have represented Huadong in numerous transactions.